3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
8
Classical hematology
5
Gastrointestinal
3
Thoracic
2
Plasma cell
1
Myeloid
1
Lymphoid
1
Breast
1
Conditions
Myelodysplastic Syndromes
361
Leukemia, Myeloid, Acute
302
Myeloproliferative Disorders
154
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
143
Precursor Cell Lymphoblastic Leukemia-Lymphoma
116
Primary Myelofibrosis
102
Leukemia, Myelomonocytic, Chronic
89
Lymphoma, Non-Hodgkin
76
Leukemia
71
Polycythemia Vera
64
Multiple Myeloma
55
Hodgkin Disease
51
Hematologic Neoplasms
49
Leukemia, Lymphocytic, Chronic, B-Cell
44
Lymphoma
41
Leukemia, Biphenotypic, Acute
41
Thrombocythemia, Essential
40
Myelodysplastic-Myeloproliferative Diseases
31
Neoplasms
29
Leukemia, Myeloid, Chronic-Phase
28
Anemia, Refractory, with Excess of Blasts
24
Recurrence
23
Anemia, Aplastic
21
Lymphoma, Mantle-Cell
20
Lymphoma, Follicular
20
Hematologic Diseases
20
Burkitt Lymphoma
20
Blastic Plasmacytoid Dendritic Cell Neoplasm
20
Blast Crisis
20
Histiocytosis, Langerhans-Cell
19
Interventions
Levofloxacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neutropenia
×
Myeloid
×
1 year
×
Clear all
NCT07528417
2026-04-22
MYELO-CAN:ABX
University of Manitoba
Phase 2
Not yet recruiting
75 enrolled